Epigenetics & Chromatin is a peer-reviewed open access scientific journal published by BioMed Central that covers the biology of epigenetics and chromatin.
 | |
| Discipline | Epigenetics |
|---|---|
| Language | English |
| Edited by | Frank Grosveld, Steven Henikoff |
| Publication details | |
| History | 2008-present |
| Publisher | |
| Yes | |
| License | Creative Commons Attribution License 4.0 |
| 4.237 | |
| Standard abbreviations | |
| ISO 4 | Epigenetics Chromatin |
| Indexing | |
| CODEN | ECPHAK |
| ISSN | 1756-8935 |
| OCLC no. | 263688252 |
| Links | |
Scope
editEpigenetics & Chromatin is a peer-reviewed open access scientific journal that publishes research related to epigenetic inheritance and chromatin-based interactions. First published in 2008 by BioMed Central, its overall aim is to understand the regulation of gene and chromosomal elements during the processes of cell division, cell differentiation, and any alterations in the environment. To date, 13 volumes have been published.[1]
Usage
editAs of October 2020, there has been over 340,000 downloads and over 750 Altmetric mentions.[2]
Metrics
edit
Impact factor
editAccording to Journal Citation Reports, it received an impact factor of 4.237[3] in 2019. Its current SCImago Journal Rank is 2.449.[4]
Citation impact
editIts 2-year and 5-year citation impact factor is 4.237[3] and 4.763,[3] respectively. Its Source Normalized Impact per Paper (SNIP) is 0.896.[4]
Editors
editIts current Journal Authority Factor (JAF) is 111.5.[5]
Editors-in-Chief
edit| Editor[6] | Institution |
|---|---|
| Frank Grosveld | Erasmus University Medical Center, Netherlands |
| Steven Henikoff | Fred Hutchinson Cancer Research Center, USA |
Editorial Board
edit| Editor[6] | Institution |
|---|---|
| Julie Ahringer | The Gurdon Institute, University of Cambridge, UK |
| Juan Ausió | University of Victoria, Canada |
| Shelley Berger | The Wistar Institute, USA |
| Timothy Bestor | Columbia University, USA |
| Yamini Dalal | National Cancer Institute, USA |
| Elzo de Wit | Netherlands Cancer Institute, The Netherlands |
| Jerome Dejardin | Institute of Human Genetics, France |
| Anne Ferguson-Smith | University of Cambridge, UK |
| Amanda Fisher | Imperial College London, UK |
| John Greally | Albert Einstein College of Medicine, USA |
| Shiv Grewal | National Institutes of Health, USA |
| Joost Gribnau | Erasmus University Medical Center, Netherlands |
| Gordon Hager | National Cancer Institute, USA |
| Steven Jacobsen | University of California, Los Angeles, USA |
| Albert Jeltsch | University of Stuttgart, Germany |
| Paul Kaufman | University of Massachusetts Medical School, USA |
| William Kelly | Emory University, USA |
| Siavash Kurdistani | University of California, Los Angeles, USA |
| Colin Logie | Radboud University Medical Centre, The Netherlands |
| Frank Lyko | German Cancer Research Center, Germany |
| Kazuhiro Maeshima | National Institute of Genetics, Japan |
| Valerio Orlando | King Abdullah University of Science and Technology, Saudi Arabia |
| Vincenzo Pirotta | Rutgers University, USA |
| Ana Pombo | Max Delbrueck Centre, Germany |
| Oliver Rando | Harvard FAS Center for Systems Biology, USA |
| Jasper Rine | University of California, Berkeley, USA |
| Wendy Robinson | BC Children's Hospital Research Institute, Canada |
| Yang Shi | Harvard Medical School, USA |
| David Spector | Cold Spring Harbor Laboratory, USA |
| Brian Strahl | University of North Carolina, USA |
| Azim Surani | The Wellcome Trust & Cancer Research UK, UK |
| David Tremethick | Australian National University, Australia |
| Jessica Tyler | MD Anderson Cancer Center, USA |
| Bas van Steensel | The Netherlands Cancer Institute, Netherlands |
| Jörn Walter | Universität des Saarlandes, Germany |
| Jerry Workman | Stowers Institute for Medical Research, USA |
| Anton Wutz | ETH Zurich, Switzerland |
| Rui-ming Xu | Chinese Academy of Sciences, China |
| Yi Zhang | Harvard Medical School, USA |
Submission guidelines
edit
Current submission guidelines are as follows:
Prior to submitting
editSubmitters must ensure that Epigenetics & Chromatin is the most suitable journal for the proposed article in addition to understanding of the costs, funding options, and copyright agreement associated with submission. Accuracy and readability of the manuscript must also be considered.[7]
During the submission process
editThe manuscript must follow all formatting rules which authors must read, understand and accept.[7]
After successful submission
editAuthors should review the peer-review policy. Authors should also be familiar with the process of manuscript transfers to a different journal, as well as how to promote the publication.[7]
Speed of the submission process
editOn average, it takes 53 days to reach a decision for reviewed manuscripts and 35 days for all manuscripts. The process of acceptance takes an average of 112 days after submission. After acceptance, it takes an average of 16 days for an article to be published.[7]
Indexing services
editAfter successful publication in Epigenetics & Chromatin, articles are also included in:[8]
Notable publications
editAs of October 2020, the most accessed articles are:[19]
- Chromatin accessibility: a window into the genome (Tsompana & Buck, 2014)[20]
- Constitutive heterochromatin formation and transcription in mammals (Saksouk et al., 2015)[21]
- Chromatin structure and DNA damage repair (Dinant et al., 2008)[22]
- Profiling genome-wide DNA methylation (Yong et al., 2016)[23]
- Additional annotation enhances potential for biologically relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip Array (Price et al., 2013)[24]
References
edit- ^ "Epigenetics & Chromatin | Volumes and issues". SpringerLink. Retrieved 2020-10-29.
- ^ "Epigenetics & Chromatin". Epigenetics & Chromatin. Retrieved 2020-10-29.
- ^ a b c "Epigenetics & Chromatin". Journal Citation Reports Science Edition. Clarivate Analytics. 2020-10-19 – via Journal Citation Reports.
- ^ a b c "Scopus preview - Scopus - Epigenetics and Chromatin". www.scopus.com. Retrieved 2020-10-29.
- ^ "Epigenetics & Chromatin". Epigenetics & Chromatin. Retrieved 2020-10-29.
- ^ a b "Epigenetics & Chromatin". Epigenetics & Chromatin. Retrieved 2020-10-29.
- ^ a b c d "Epigenetics & Chromatin". Epigenetics & Chromatin. Retrieved 2020-11-04.
- ^ "Journal archiving". www.biomedcentral.com. Retrieved 2020-10-29.
- ^ a b "Web of Science Master Journal List". Web of Science. Retrieved 2020-11-05.
- ^ "CAS Source Index (CASSI)". cassi.cas.org. Retrieved 2020-11-05.
- ^ DOAJ. "Directory of Open Access Journals". doaj.org. Retrieved 2020-11-05.
- ^ "Embase Coverage and Content | Elsevier". www.elsevier.com. Retrieved 2020-11-05.
- ^ "List of Journals Indexed for MEDLINE". NCBI. Retrieved 2020-11-05.
- ^ Epigenetics and chromatin. Biomed Central Ltd Biomed Central. Retrieved 2020-11-05.
{{cite book}}:|website=ignored (help) - ^ "List of All Journals Cited in PubMed®". www.nlm.nih.gov. Retrieved 2020-11-05.
- ^ "Archive of "Epigenetics & Chromatin"". www.ncbi.nlm.nih.gov. Retrieved 2020-11-05.
- ^ "Epigenetics & Chromatin". Socolar. Retrieved 2020-11-05.
- ^ "Zetoc : Journals". zetoc.jisc.ac.uk. Retrieved 2020-11-05.
- ^ "Epigenetics & Chromatin". Epigenetics & Chromatin. Retrieved 2020-10-29.
- ^ Tsompana, Maria; Buck, Michael J. (2014-11-20). "Chromatin accessibility: a window into the genome". Epigenetics & Chromatin. 7 (1): 33. doi:10.1186/1756-8935-7-33. ISSN 1756-8935. PMC 4253006. PMID 25473421.
- ^ Saksouk, Nehmé; Simboeck, Elisabeth; Déjardin, Jérôme (2015-01-15). "Constitutive heterochromatin formation and transcription in mammals". Epigenetics & Chromatin. 8 (1): 3. doi:10.1186/1756-8935-8-3. ISSN 1756-8935. PMC 4363358. PMID 25788984.
- ^ Dinant, Christoffel; Houtsmuller, Adriaan B.; Vermeulen, Wim (2008-11-12). "Chromatin structure and DNA damage repair". Epigenetics & Chromatin. 1 (1): 9. doi:10.1186/1756-8935-1-9. ISSN 1756-8935. PMC 2596136. PMID 19014481.
- ^ Yong, Wai-Shin; Hsu, Fei-Man; Chen, Pao-Yang (2016-06-29). "Profiling genome-wide DNA methylation". Epigenetics & Chromatin. 9 (1): 26. doi:10.1186/s13072-016-0075-3. ISSN 1756-8935. PMC 4926291. PMID 27358654.
- ^ Price, E. Magda; Cotton, Allison M.; Lam, Lucia L.; Farré, Pau; Emberly, Eldon; Brown, Carolyn J.; Robinson, Wendy P.; Kobor, Michael S. (2013-03-03). "Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array". Epigenetics & Chromatin. 6 (1): 4. doi:10.1186/1756-8935-6-4. ISSN 1756-8935. PMC 3740789. PMID 23452981.